The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2020
Filed:
Oct. 05, 2018
Applicants:
Centre National DE LA Recherche Scientifique, Paris, FR;
Institut Curie, Paris, FR;
Universite DE Montpellier, Montpellier, FR;
Inventors:
Jamal Tazi, Clapiers, FR;
David Grierson, Vancouver, CA;
Florence Mahuteau-Betzer, Saint-Remy-les-Chevreuse, FR;
Pierre Roux, Saint Gely du Fesc, FR;
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;
INSTITUT CURIE, Paris, FR;
UNIVERSITE DE MONTPELLIER, Montpellier, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 249/06 (2006.01); C07D 213/38 (2006.01); C07D 213/56 (2006.01); C07D 213/74 (2006.01); C07D 213/75 (2006.01); C07D 213/82 (2006.01); C07D 233/61 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07C 237/30 (2006.01); C07D 233/64 (2006.01);
U.S. Cl.
CPC ...
C07D 249/06 (2013.01); C07C 237/30 (2013.01); C07D 213/38 (2013.01); C07D 213/56 (2013.01); C07D 213/74 (2013.01); C07D 213/75 (2013.01); C07D 213/82 (2013.01); C07D 233/61 (2013.01); C07D 233/64 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01);
Abstract
Compounds and pharmaceutically acceptable salts thereof that may be used to treat a disease, for example, Duchenne muscular dystrophy, AIDS, and progeria. The compounds and pharmaceutically acceptable salts thereof may be part of a pharmaceutical composition including a pharmaceutically acceptable support.